Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation
Company Logo

Destroying Cancer at the Speed of Light®

Clinical Study Underway (75 of 100 Patients Treated)
Expected to complete enrollment at the end of 2024
Expected to complete study at the end of 2026


Bullboard - Investor Discussion Forum Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called... see more

TSXV:TLT - Post Discussion

Theralase Technologies Inc. > On his last day at Theralase, Shawn Shirazi
View:
Post by Eoganacht on Aug 20, 2021 11:21am

On his last day at Theralase, Shawn Shirazi

...is shaking the dust from his feet. He was a CEO with no skin in the game. He sold the entirety of his 5,000 share holding for the princely sum of $950. 

Filing Details
 
Issuer Name    Theralase Technologies Inc.
Insider Name    Shirazi, Shawn
Relationship as filed with regulators    5 - Senior Officer of Issuer
Transaction ID    3792011
Filing Date    Aug 20, 2021
Transaction Date    Aug 20, 2021
Security Type    Common Shares
Transaction Nature    10 - Acquisition or disposition in the public market
Ownership Type    Direct Ownership
# or Value Acquired or Disposed of    -5,000
Unit Price or Exercise Price    $0.190
Closing Balance    0
Comment by menoalittle on Aug 20, 2021 12:02pm
I'm inclined to doubt that it was possible to "slow walk" things at Theralase any slower than they were under Shawn's "leadership."  Not saying there were... but quite frankly it's enough to make me wonder (not for the first time, actually... so it wouldn't surprise me in the slightest) if some sort of alterior motives (or incentives) were involved.  ...more  
Comment by menoalittle on Aug 20, 2021 12:39pm
it never made much sense to me why he (as CEO of the company) only held so few shares...  but, maybe now it does...
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.


Connect with V.TLT



Investor Presentation

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 75 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

FACT SHEET

View the Presentation

The Watchlist

The Watchlist
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Investment Opportunity

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 72 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

Facebook

Contact Us

Address:
41 Hollinger Road
Toronto, ON M4B 3G4
Canada

Toll Free:
1-866-THE-LASE (843-5273)
Local Phone:
416-699-LASE (5273)

Email:
info@theralase.com

Fax:
416-699-5250